Hyaluronidase recruits mesenchymal-like cells to the lung and ameliorates fibrosis

Fibrogenesis and Tissue Repair

Volumn 4, Issue 1, 2011, Pages

  Bitencourt, Claudia S ^a   Pereira, Priscilla A T ^a   Ramos, Simone G ^a   Sampaio, Suely V ^a   Arantes, Eliane C ^a   Aronoff, David M ^b   Faccioli, Lúcia H ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79551711222     PISSN: None     EISSN: 17551536     Source Type: Journal    
DOI: 10.1186/1755-1536-4-3     Document Type: Article

References (41)

1. Kemparaju K, Girish KS. Snake venom hyaluronidase: a therapeutic target. Cell Biochem Funct 2006, 24:7-12. 10.1002/cbf.1261, 16245359.
2. Hynes WL, Dixon AR, Walton SL, Aridgides LJ. The extracellular hyaluronidase gene (hylA) of streptococcus pyogenes. FEMS Microbiol Lett 2000, 184:109-112. 10.1111/j.1574-6968.2000.tb08999.x, 10689175.
3. Jiang D, Liang J, Noble PW. Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 2007, 23:435-461. 10.1146/annurev.cellbio.23.090506.123337, 17506690.
4. Menzel EJ, Far C. Hyaluronidase and its substrate: biochemistry, biological activities and therapeutic uses. Cancer Lett 1998, 131:3-11. 10.1016/S0304-3835(98)00195-5, 9839614.
5. Savani RC, Hou G, Liu P, Wang C, Simons E, Grimm PC, Stern R, Greenberg AH, DeLisser HM, Khalil N. A role for hyaluronan in macrophage accumulation and collagen deposition after bleomycin-induced lung injury. Am J Respir Cell Mol Biol 2000, 23:475-484.
6. Dentener MA, Vernooy JH, Hendriks S, Wouters EF. Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation. Thorax 2005, 60:114-119. 10.1136/thx.2003.020842, 1747307, 15681498.
7. Loebinger MR, Aguilar S, Janes SM. Therapeutic potential of stem cells in lung disease: progress and pitfalls. Clin Sci (Lond) 2008, 114:99-108. 10.1042/CS20070073, 18062775.
8. Meirelles LS, Fontes AM, Covas DT, Caplan AI. Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev 2009, 20:419-427. 10.1016/j.cytogfr.2009.10.002, 19926330.
9. Siegel G, Schäfer R, Dazzi F. The immunosuppressive properties of mesenchymal stem cells. Transplantation 2009, 87:S45-S49. 10.1097/TP.0b013e3181a285b0, 19424005.
10. Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, Ilancheran S, Boyd R, Trounson A. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. Am J Pathol 2009, 175:303-313. 10.2353/ajpath.2009.080629, 2708816, 19497992.
11. Soncini M, Vertua E, Gibelli L, Zorzi F, Denegri M, Albertini A, Wengler GS, Parolini O. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med 2007, 1:296-305. 10.1002/term.40, 18038420.
12. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008, 8:726-736. 10.1038/nri2395, 19172693.
13. Siniscalco D, Sullo N, Maione S, Rossi F, D'Agostino B. Stem cell therapy: the great promise in lung disease. Ther Adv Respir Dis 2008, 2:173-177. 10.1177/1753465808092340, 19124369.
14. García-Castro J, Trigueros C, Madrenas J, Pérez-Simón JA, Rodriguez R, Menendez P. Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool. J Cell Mol Med 2008, 12:2552-2565.
15. Benjamin DK, Miller WC, Bayliff S, Martel L, Alexander KA, Martin PL. Infections diagnosed in the first year after pediatric stem cell transplantation. Pediatr Infect Dis J 2002, 21:227-234. 10.1097/00006454-200203000-00013, 12005087.
16. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, Phinney DG. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 2003, 100:8407-8411. 10.1073/pnas.1432929100, 166242, 12815096.
17. Lawrence T, Willoughby DA, Gilroy DW. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2002, 2:787-795. 10.1038/nri915, 12360216.
18. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435. 10.1038/nature07201, 18650913.
19. Mancuso F, Flower RJ, Perretti M. Leukocyte transmigration, but not rolling or adhesion, is selectively inhibited by dexamethasone in the hamster post-capillary venule. Involvement of endogenous lipocortin 1. J Immunol 1995, 155:377-386.
20. Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001, 294:1871-1875. 10.1126/science.294.5548.1871, 11729303.
21. Ford-Hutchinson AW. Regulation of the production and action of leukotrienes by MK-571 and MK-886. Adv Prostaglandin Thromboxane Leukot Res 2001, 21:9-16.
22. Warner TD, Giuliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA 1999, 96:7563-7568. 10.1073/pnas.96.13.7563, 22126, 10377455.
23. Suzuki T, Chow CW, Downey GP. Role of innate immune cells and their products in lung immunopathology. Int J Biochem Cell Biol 2008, 40:1348-1361. 10.1016/j.biocel.2008.01.003, 18272422.
24. Djouad F, Bouffi C, Ghannam S, Noël D, Jorgensen C. Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases. Nat Rev Rheumatol 2009, 5:392-399. 10.1038/nrrheum.2009.104, 19568253.
25. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317. 10.1080/14653240600855905, 16923606.
26. Wang X, Hisha H, Taketani S, Adachi Y, Li Q, Cui W, Cui Y, Wang J, Song C, Mizokami T, et al. Characterization of mesenchymal stem cells isolated from mouse fetal bone marrow. Stem Cells 2006, 24:482-493. 10.1634/stemcells.2005-0219, 16179426.
27. Baddoo M, Hill K, Wilkinson R, Gaupp D, Hughes C, Kopen GC, Phinney DG. Characterization of mesenchymal stem cells isolated from murine bone marrow by negative selection. J Cell Biochem 2003, 15:1235-1249.
28. Zhao S, Wehner R, Bornhäuser M, Wassmuth R, Bachmann M, Schmitz M. Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders. Stem Cells Dev 2010, 19:607-614. 10.1089/scd.2009.0345, 19824807.
29. Nardi NB, Meirelles LS. Mesenchymal stem cells: isolation, in vitro expansion and characterization. Handb Exp Pharmacol 2006, 174:249-282. full_text, 16370331.
30. McQualter JL, Brouard N, Williams B, Baird BN, Sims-Lucas S, Yuen K, Nilsson SK, Simmons PJ, Bertoncello I. Endogenous fibroblastic progenitor cells in the adult mouse lung are highly enriched in the sca-1 positive cell fraction. Stem Cells 2009, 27:623-633. 10.1634/stemcells.2008-0866, 19074419.
31. Le Blanc K, Pittenger M. Mesenchymal stem cells: progress toward promise. Cytotherapy 2005, 7:36-45. 10.1080/14653240510018118, 16040382.
32. Teisanu RM, Lagasse E, Whitesides JF, Stripp BR. Prospective isolation of bronchiolar stem cells based upon immunophenotypic and autofluorescence characteristics. Stem Cells 2009, 27:612-622. 10.1634/stemcells.2008-0838, 2773680, 19056905.
33. Wang Q, Wang Y, Hyde DM, Gotwals PJ, Koteliansky VE, Ryan ST, Giri SN. Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters. Thorax 1999, 54:805-812. 10.1136/thx.54.9.805, 1745567, 10456973.
34. Teder P, Vandivier RW, Jiang D, Liang J, Cohn L, Puré E, Henson PM, Noble PW. Resolution of lung inflammation by CD44. Science 2002, 296:155-158. 10.1126/science.1069659, 11935029.
35. Strieter RM, Keeley EC, Hughes MA, Burdick MD, Mehrad B. The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J Leukoc Biol 2009, 86:1111-1118. 10.1189/jlb.0309132, 2774878, 19581373.
36. Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 2004, 113:243-252. 310750, 14722616.
37. Engelhard D, Cordonnier C, Shaw PJ, Parkalli T, Guenther C, Martino R, Dekker AW, Prentice HG, Gustavsson A, Nurnberger W, Ljungman P. Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey. Br J Haematol 2002, 117:444-450. 10.1046/j.1365-2141.2002.03457.x, 11972532.
38. Pessini AC, Takao TT, Cavalheiro EC, Vichnewski W, Sampaio SV, Giglio JR, Arantes EC. A hyaluronidase from Tityus serrulatus scorpion venom: isolation, characterization and inhibition by flavonoids. Toxicon 2001, 39:1495-1504. 10.1016/S0041-0101(01)00122-2, 11478957.
39. Medeiros AI, Silva CL, Malheiro A, Maffei CM, Faccioli LH. Leukotrienes are involved in leukocyte recruitment induced by live Histoplasma capsulatum or by the beta-glucan present in their cell wall. Br J Pharmacol 1999, 128:1529-1537. 10.1038/sj.bjp.0702912, 1571769, 10602333.
40. Hecker L, Vittal R, Jones T, Jagirdar R, Luckhardt TR, Horowitz JC, Pennathur S, Martinez FJ, Thannickal VJ. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med 2009, 15:1077-1081. 10.1038/nm.2005, 2743335, 19701206.
41. Pádua AI, Silva CL, Ramos SG, Faccioli LH, Martinez JA. Influence of a DNA-hsp65 vaccine on bleomycin-induced lung injury. J Bras Pneumol 2008, 34:891-899.